Author | Frederick Locke, MD


Investigating CAR T-Cell Therapy in Patients With DLBCL, FL, and Other Lymphomas

March 07, 2018

ByFrederick Locke, MD

In this interview, Dr. Frederick Locke discusses the promise of CAR T-cell therapy for lymphomas, and how this gene therapy could offer hope for patients who don't respond to standard treatments.

CAR T-Cell Therapy Yields High Response Rate in Aggressive Lymphoma

April 07, 2017

ByFrederick Locke, MD

This video reviews results of the ZUMA-1 trial, which tested the CAR T-cell therapy axicabtagene ciloleucel in patients with advanced non-Hodgkin lymphoma.